Over-the-counter drug · UNAPPROVED DRUG OTHER
Maximum Strength Urinary Pain Relief NDC 11673-270
phenazopyridine hydrochloride · Phenazopyridine hydrochloride 99.5 mg/1 · Tablet · Oral · TARGET CORPORATION
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 11673-270-24 | 11673027024 | 1 BLISTER PACK in 1 CARTON (11673-270-24) / 24 TABLET in 1 BLISTER PACKMarketed from Jan 25, 2023 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Maximum Strength Urinary Pain Relief
- Generic name (nonproprietary)
- phenazopyridine hydrochloride
- Active ingredients
- Phenazopyridine hydrochloride — 99.5 mg/1
- Dosage form
- Tablet
- Route
- Oral
- Labeler
- TARGET CORPORATION
- Product type
- Over-the-counter drug
- Marketing category
- Unapproved drug (other)
- Marketing start
- Listing expires
- Identifiers
- Product ID 11673-270_664b1fe6-08a3-4929-a58b-569bff251571SPL ID 664b1fe6-08a3-4929-a58b-569bff251571SPL set ID e6e27e7f-d04c-5a49-e053-2a95a90a776aRxCUI 1094147UNII 0EWG668W17
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N411673027024followed by a unit qualifier and the quantityPackage 11673-0270-24. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
Use Relief from urinary pain, burning, urgency and frequency associated with urinary tract infections. Treatment should not exceed 2 days; see Directions
Excerpt only. Read the full label for complete information.